Skip to main content
. 2018 Dec 31;11(Suppl 6):118. doi: 10.1186/s12920-018-0434-y

Fig. 1.

Fig. 1

IsomiR biomarker subtyping methodology. The framework of the novel methodology designed for breast cancer biomarker subtyping is composed of three discrete steps from isomiR expression profiling to identification of key isomiRs used as novel biomarkers